These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26141438)

  • 1. Physical factors affecting chloroquine binding to melanin.
    Schroeder RL; Pendleton P; Gerber JP
    Colloids Surf B Biointerfaces; 2015 Oct; 134():8-16. PubMed ID: 26141438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
    Ono C; Tanaka M
    J Pharm Pharmacol; 2003 Aug; 55(8):1127-33. PubMed ID: 12956903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of memantine to melanin: influence of type of melanin and characteristics.
    Koeberle MJ; Hughes PM; Skellern GG; Wilson CG
    Pharm Res; 2003 Oct; 20(10):1702-9. PubMed ID: 14620529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanin standard method: particle description.
    Zeise L; Murr BL; Chedekel MR
    Pigment Cell Res; 1992 Sep; 5(3):132-42. PubMed ID: 1409450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of Ocular Melanin Drug Binding Assays. Alternatives to the Model of Multiple Classes of Independent Sites.
    Manzanares JA; Rimpelä AK; Urtti A
    Mol Pharm; 2016 Apr; 13(4):1251-7. PubMed ID: 26820602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous removal of the model pharmaceutical chloroquine from water using melanin-covered Escherichia coli in a membrane bioreactor.
    Lindroos M; Hörnström D; Larsson G; Gustavsson M; van Maris AJA
    J Hazard Mater; 2019 Mar; 365():74-80. PubMed ID: 30412809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo.
    Ono C; Yamada M; Tanaka M
    J Pharm Pharmacol; 2003 Dec; 55(12):1647-54. PubMed ID: 14738591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies.
    Schroeder RL; Gerber JP
    Toxicol Rep; 2014; 1():963-968. PubMed ID: 28962308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of in vitro α-1 adrenergic receptor antagonist binding capacity to biologic melanin using tandem mass spectrometry.
    Gaynes JS; Micic C; Gaynes BI; Borgia JA
    Curr Eye Res; 2013 Dec; 38(12):1214-20. PubMed ID: 24047464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro melanin binding of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist.
    Yamada T; Okuyama Y; Mukai H
    Arzneimittelforschung; 2001; 51(4):299-303. PubMed ID: 11367870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectroelectrochemical Reverse Engineering DemonstratesThat Melanin's Redox and Radical Scavenging Activities Are Linked.
    Kim E; Kang M; Tschirhart T; Malo M; Dadachova E; Cao G; Yin JJ; Bentley WE; Wang Z; Payne GF
    Biomacromolecules; 2017 Dec; 18(12):4084-4098. PubMed ID: 29032671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity of ocular acid-insoluble melanin for drugs in vitro.
    Tsuchiya M; Hayasaka S; Mizuno K
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):822-5. PubMed ID: 3570692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of drugs to eye melanin is not predictive of ocular toxicity.
    Leblanc B; Jezequel S; Davies T; Hanton G; Taradach C
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):124-32. PubMed ID: 9927562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of chemicals to melanins re-examined: adsorption of some drugs to the surface of melanin particles.
    Bridelli MG; Ciati A; Crippa PR
    Biophys Chem; 2006 Jan; 119(2):137-45. PubMed ID: 16139945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin.
    Stepień KB; Wilczok T
    Biochem Pharmacol; 1982 Nov; 31(21):3359-65. PubMed ID: 6816244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule modulators of aggregation in synthetic melanin polymerizations.
    Belitsky JM; Ellowitz MZ; Lye D; Kilbo AL
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5503-7. PubMed ID: 22835871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Melanin Characteristics on Drug Binding Properties.
    Jakubiak P; Lack F; Thun J; Urtti A; Alvarez-Sánchez R
    Mol Pharm; 2019 Jun; 16(6):2549-2556. PubMed ID: 30998378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonic chorioretinopathy: a chloroquine vs control study.
    Kaplan LJ; Holasek E
    Ann Ophthalmol; 1983 Dec; 15(12):1132-4. PubMed ID: 6660693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1H NMR spectroscopic characterization of solutions of Sepia melanin, Sepia melanin free acid and human hair melanin.
    Katritzky AR; Akhmedov NG; Denisenko SN; Denisko OV
    Pigment Cell Res; 2002 Apr; 15(2):93-7. PubMed ID: 11936275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrared and water sorption studies of the hydration structure and mechanism in natural and synthetic melanin.
    Bridelli MG; Crippa PR
    J Phys Chem B; 2010 Jul; 114(29):9381-90. PubMed ID: 20604565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.